Abstract
Diabetes is a proinflammatory state and inflammation is crucial in the genesis of vascular complications. While there are many anti-inflammatory strategies, most of which have been shown to reduce inflammation in diabetes, there is sparse data on reduction in cardiovascular events (CVEs). To date, the only anti-inflammatory strategies that have been shown to reduce CVE in diabetes include statins, angiotensin receptor blockers, metformin, and pioglitazone. We also discuss the role of novel emerging therapies.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 121-123 |
| Number of pages | 3 |
| Journal | Clinical Pharmacology and Therapeutics |
| Volume | 98 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 1 2015 |
ASJC Scopus subject areas
- Medicine(all)
Fingerprint Dive into the research topics of 'Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease'. Together they form a unique fingerprint.
Cite this
Jialal, I., & Devaraj, S. (2015). Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease. Clinical Pharmacology and Therapeutics, 98(2), 121-123. https://doi.org/10.1002/cpt.105